Page last updated: 2024-08-18

isomethyleugenol and Opioid-Related Disorders

isomethyleugenol has been researched along with Opioid-Related Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fu, X; Tang, H; Xun, Y; Yu, J; Zhang, J; Zhang, R; Zhang, Y; Zhu, F1
Bleich, S; Frieling, H; Glahn, A; Groh, A; Heberlein, A; Hillemacher, T; Kleimann, A; Lichtinghagen, R; Rehme, MK; Schuster, R; Taschner, L1

Other Studies

2 other study(ies) available for isomethyleugenol and Opioid-Related Disorders

ArticleYear
Methylation and expression quantitative trait loci rs1799971 in the OPRM1 gene and rs4654327 in the OPRD1 gene are associated with opioid use disorder.
    Neuroscience letters, 2023, 09-25, Volume: 814

    Topics: Genotype; Humans; Methylation; Opioid-Related Disorders; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Receptors, Opioid, delta; Receptors, Opioid, mu

2023
Elevated methylation and decreased serum concentrations of BDNF in patients in levomethadone compared to diamorphine maintenance treatment.
    European archives of psychiatry and clinical neuroscience, 2017, Volume: 267, Issue:1

    Topics: Adult; Analgesics, Opioid; Brain-Derived Neurotrophic Factor; Case-Control Studies; Depression; Epigenesis, Genetic; Female; Heroin; Humans; Male; Methadone; Methylation; Middle Aged; Opioid-Related Disorders; Promoter Regions, Genetic; Prospective Studies; Psychiatric Status Rating Scales; Statistics, Nonparametric; Surveys and Questionnaires; Visual Analog Scale

2017